Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

life_sciences_scotland_edit

Life Sciences Scotland appoints two MSPs to their Industry Leadership Group

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Life Sciences Scotland, Scotland, economic development, pharma

Life Sciences Scotland, an organisation focused towards developing the life sciences industry in the northernmost constituent country of the United …

Appointment
kenneth_c

Kenneth Frazier to continue as CEO as MSD rescinds mandatory retirement policy

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kenneth Frazier, MSD, pharma

MSD has pitched a curveball with the news that the company has rescinded its policy mandating that Chief Executive Officers …

News
pharmafocus_october_2018

The October 2018 issue of Pharmafocus is available to read online now!

September 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hurricane Florence, NHS, Pharmafocus, US, biosimilars, market access, mental health, pharma

The October issue of Pharmafocus is available to read in full online now!Hurricane Florence lashed across North America’s Southeast coast …

News
alexion_sign

Alexion’s Soliris almost entirely eliminates relapses in rare neuromyelitis optica spectrum disorder

September 26, 2018
Research and Development Alexion, neuromyelitis optica spectrum disorder, pharma, rare disease, soliris

Alexion has revealed new Phase 3 findings for Soliris (eculizumab), showing the drug met its primary endpoint in the treatment …

News

Roche’s Tecentriq+chemo combo shows first-line benefit in small cell lung cancer

September 26, 2018
Research and Development Cancer, Combo, Roche, chemotherapy, lung cancer, pharma, tecentriq

Roche has unveiled new Phase 3 data for its cancer immunotherapy Tecentriq (atezolizumab) in combination with carboplatin and etoposide chemotherapy …

News
astrazeneca_building_white

AstraZeneca chalks up European approval for Imfinzi in locally advanced, unresectable lung cancer

September 25, 2018
Manufacturing and Production, Sales and Marketing AstraZeneca, Cancer, MedImmune, NSCLC, lung cancer, pharma

AstraZeneca and its global biologics R&D arm MedImmune have announced the approval by the European Commission of Imfinzi (durvalumab) as …

News
7359dba7-e1da-4eb4-8765-58da6178899b

Sarepta’s Exondys 51 hit with negative CHMP opinion in Duchenne muscular dystrophy

September 24, 2018
Research and Development, Sales and Marketing CHMP, Duchenne Muscular Dystophy, EMA, Europe, Exondys 51, pharma, sarepta

Sarepta Therapeutics has been rocked by a hurdle in its pursuit of regulatory approval in Europe, as the company revealed …

News
astrazeneca-sign

AstraZeneca’s Farxiga cuts heart risk in type 2 diabetes patients

September 24, 2018
Research and Development, Sales and Marketing AstraZeneca, diabetes, farxiga, pharma

AstraZeneca has unveiled new Phase 3 data for its SGLT2 inhibitor Farxiga (dapagliflozin), showing with the drug demonstrating positive findings …

News
humira_abbott__4

EU approval for Mylan and Fujifilm’s Humira biosimilar

September 21, 2018
Medical Communications, Sales and Marketing EU, Europe, Humira, Mylan, biosimilar, pharma

The European Commission has approved its fifth biosimilar of the world’s best-selling drug, Abbvie’s Humira (adalimumab), granting marketing authorisation to …

News
alzheimers_pharmafocus_accompanying_image

A goal in mind: Transforming the way Alzheimer’s disease is diagnosed and treated

September 20, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Roche, pharma

Dr Rachelle Doody, Global Head of Neurodegeneration at Roche/Genentech, discusses key learnings from clinical trials in Alzheimer’s disease, and how …

Feature

Astellas’ chronic kidney drug shows superiority at Phase 3

September 20, 2018
Research and Development Astellas, chronic kidney disease, pharma, roxadustat

Astellas has revealed new Phase 3 data for roxadustat in the treatment of chronic kidney disease (CKD) in patients with …

News
sicorbio

FDA greenlights Teva’s migraine drug Ajovy in two dosage options

September 20, 2018
Sales and Marketing FDA, Teva, US, ajovy, migraine, pharma

Israeli drugmaker Teva has announced that its calcitonin gene-related peptide (CGRP) inhibitor Ajovy (remanezumab-vfrm) has received FDA approval as a …

News
almirall-605x338

Almirall’s Ilumetri scores EU approval in chronic plaque psoriasis

September 19, 2018
Research and Development, Sales and Marketing Almirall, EADV 2018, Ilumetri, pharma, psoriasis

Hot on the heels of the European Academy of Dermatology and Venereology Congress (EADV) 2018 where psoriasis took centre stage, …

News

Novartis to relocate Arnhem operations to Amsterdam, 400 jobs affected

September 19, 2018
Manufacturing and Production, Research and Development Netherlands, Novartis, amsterdam, pahrma, pharma

Novartis has announced it is to relocate its operations in Arnhem in the Netherlands to the capital city of Amsterdam, …

News
cruk

Cancer Research UK announces new £14m research hub in London

September 18, 2018
Manufacturing and Production, Research and Development CRUK, Cancer, pharma

Cancer Research UK has announced a £14 million investment to build a new hub in London for cancer research and …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026